STOCK TITAN

Wave Life Sciences to Present at the Jefferies 2020 Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Wave Life Sciences (Nasdaq: WVE) announced that CEO Paul Bolno will present at the Jefferies 2020 Virtual Healthcare Conference on June 4, 2020, at 2:00 p.m. ET. The presentation will focus on the company's mission to develop life-changing genetic treatments using their proprietary PRISM platform. A live webcast will be available on the investor relations page of Wave's website, with a replay accessible for 90 days post-event. Wave Life Sciences is dedicated to addressing genetically defined diseases to improve patient futures.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present virtually at the Jefferies 2020 Virtual Healthcare Conference on June 4, 2020 at 2:00 p.m. ET.

A live webcast of the presentation will be available on the investor relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com   

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com 

 

FAQ

When is the Wave Life Sciences presentation at the Jefferies Virtual Healthcare Conference?

The Wave Life Sciences presentation is scheduled for June 4, 2020, at 2:00 p.m. ET.

Who is presenting for Wave Life Sciences at the Jefferies conference?

CEO Paul Bolno will present for Wave Life Sciences at the Jefferies conference.

Where can I watch the Wave Life Sciences presentation?

The presentation can be viewed live on the investor relations page of the Wave Life Sciences corporate website.

How long will the replay of the Wave Life Sciences presentation be available?

The replay will be available for 90 days following the event.

What does Wave Life Sciences focus on in their research?

Wave Life Sciences focuses on developing life-changing treatments for genetically defined diseases using their PRISM platform.

Wave Life Sciences Ltd. Ordinary Shares

NASDAQ:WVE

WVE Rankings

WVE Latest News

WVE Stock Data

2.06B
129.46M
15.04%
78.65%
4.23%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SINGAPORE